A detailed history of Delphi Management Inc /Ma/ transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Delphi Management Inc /Ma/ holds 8,246 shares of LH stock, worth $1.89 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares
8,246
Previous 3,510 134.93%
Holding current value
$1.89 Million
Previous $767,000 118.77%
% of portfolio
1.37%
Previous 0.59%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 23, 2024

BUY
$192.5 - $216.35 $911,680 - $1.02 Million
4,736 Added 134.93%
8,246 $1.68 Million
Q1 2024

May 21, 2024

BUY
$209.01 - $232.56 $85,694 - $95,349
410 Added 13.23%
3,510 $767,000
Q4 2023

May 20, 2024

BUY
$197.69 - $227.29 $612,839 - $704,599
3,100 New
3,100 $705,000
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $1.49 Million - $1.67 Million
-5,417 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$251.87 - $278.14 $15,615 - $17,244
62 Added 1.16%
5,417 $1.49 Million
Q1 2021

May 14, 2021

SELL
$204.88 - $255.03 $631,645 - $786,257
-3,083 Reduced 36.54%
5,355 $1.37 Million
Q3 2019

Oct 07, 2019

SELL
$159.77 - $178.1 $222,080 - $247,559
-1,390 Reduced 14.14%
8,438 $1.42 Million
Q2 2019

Aug 20, 2019

SELL
$144.16 - $172.9 $36,328 - $43,570
-252 Reduced 2.5%
9,828 $1.7 Million
Q1 2019

May 13, 2019

SELL
$123.7 - $156.3 $309,126 - $390,593
-2,499 Reduced 19.87%
10,080 $1.54 Million
Q4 2018

Feb 22, 2019

SELL
$120.82 - $174.09 $67,659 - $97,490
-560 Reduced 4.26%
12,579 $1.59 Million
Q3 2018

Nov 13, 2018

SELL
$167.67 - $188.27 $106,805 - $119,927
-637 Reduced 4.62%
13,139 $2.28 Million
Q2 2018

Aug 20, 2018

BUY
$160.33 - $189.41 $2.21 Million - $2.61 Million
13,776 New
13,776 $2.42 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Delphi Management Inc /Ma/ Portfolio

Follow Delphi Management Inc /Ma/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delphi Management Inc /Ma/, based on Form 13F filings with the SEC.

News

Stay updated on Delphi Management Inc /Ma/ with notifications on news.